Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Brain Neoplasms 12Glioblastoma 11Glioma 6Neoplasm Metastasis 4Carcinoma, Renal Cell 4Astrocytoma 4Oligodendroglioma 3Meningioma 3Gliosarcoma 3Paraganglioma 2Melanoma 2Kidney Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pheochromocytoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neurofibromatosis 2 1Neurofibromatosis 1 1Neurofibromatoses 1Neoplasms 1Multiple Myeloma 1

Interventions

Filgrastim 13Temozolomide 9Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Cyclophosphamide 5sargramostim 4Magnetic Resonance Spectroscopy 4Irinotecan 4Etoposide 4Topotecan 3Thiotepa 3Radiotherapy 3Oxaliplatin 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Busulfan 3etoposide phosphate 2Vorinostat 2Vincristine 2Specimen Handling 2Psychiatric Rehabilitation 2Melphalan 2Ifosfamide 2Erlotinib Hydrochloride 2Cyproheptadine 2Cisplatin 2Carmustine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Sunitinib × CNS × Clear all
NCT01462695 2015-08-27

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled 8 charts
CNS

Familial ependymoma, Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡